Analytical approach:
The analysis was based on a probabilistic decision model with a lifetime horizon. The authors stated that the perspective of the UK NHS was adopted.
Effectiveness data:
The clinical data were from a selection of relevant published studies and some expert opinions. Most of the evidence came from a health technology assessment (HTA) of the cost-effectiveness of cochlear implants in young children that was conducted in the UK (Bond, et al. 2009, see ‘Other Publications of Related Interest’ below for bibliographic details). A key input of the model was the cumulative survival of the cochlear device.
Monetary benefit and utility valuations:
The utility values were estimated in two ways: using the time trade-off technique and the visual analogue scale (VAS). Time trade-off was used in the base case, while the VAS was used for an alternative scenario. The estimates were elicited from a representative sample of 180 people, including 32 clinicians or researchers, 82 undergraduate students, and 66 parents of disabled children (not hearing impaired) or members of the public.
Measure of benefit:
Quality-adjusted life-years (QALYs) were the summary benefit measure and they were discounted at an annual rate of 3.5%.
Cost data:
The economic analysis included the costs of cochlear implantation, maintenance, management of internal and external device failure, acoustic hearing aid, treatment of complications in an implanted ear, and processor upgrading. All economic estimates were from the HTA report, which collected the data from published studies. The costs were in UK pounds sterling (£), for the price year 2007, and a 3.5% annual discount rate was applied.
Analysis of uncertainty:
A deterministic sensitivity analysis was undertaken on the costs of tuning and maintenance, which were increased by 25% and by 50% of their base values. Additional analyses were carried out considering utility estimates from each group, who provided them, separately (clinicians, students, and parents). Three thousand Monte Carlo simulations were run to estimate the projected costs and benefits of the alternative strategies in a hypothetical cohort of 3,000 children.